We would like to thank the Laboratory Animal Resource Center (LARC), Indiana University, for their support and the veterinarian care of the animals during the study. This work was partly supported by the National Institutes of Health grants NR015676, NR013898, and DK125835 and the Department of Defense grant W81XWH-11-2-0142. In addition, this work benefited from the following National Institutes of Health awards: GM077185, GM069589, DK076566, AI097511, and NS42617.

Developing a Long-Term Swine Model for Biofilm-Infected Burn Wound Studies

<ol>
	<li>Goodwine, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pyruvate-depleting+conditions+induce+biofilm+dispersion+and+enhance+the+efficacy+of+antibiotics+in+killing+biofilms+in+vitro+and+in+vivo.">Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.</a> Scientific Reports. 9 (1), 3763 (2019).</li><li>Sen, C. K., Roy, S., Mathew-Steiner, S. S., Gordillo, G. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biofilm+management+in+wound+care.">Biofilm management in wound care.</a> Plastic and Reconstructive Surgery. 148 (2), 275-288 (2021).</li><li>Church, D., Elsayed, S., Reid, O., Winston, B., Lindsay, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Burn+wound+infections.">Burn wound infections.</a> Clinical Microbiology Reviews. 19 (2), 403-434 (2006).</li><li>Nguyen, T. T., Gilpin, D. A., Meyer, N. A., Herndon, D. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Current+treatment+of+severely+burned+patients.">Current treatment of severely burned patients.</a> Annals of Surgery. 223 (1), 14-25 (1996).</li><li>Eriksson, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+wounds:+Treatment+consensus.">Chronic wounds: Treatment consensus.</a> Wound Repair and Regeneration. 30 (2), 156-171 (2022).</li><li>Lebeaux, D., Chauhan, A., Rendueles, O., Beloin, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=From+in+vitro+to+in+vivo+models+of+bacterial+biofilm-related+infections.">From in vitro to in vivo models of bacterial biofilm-related infections.</a> Pathogens. 2 (2), 288-356 (2013).</li><li>Ganesh, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+wound+biofilm+model.">Chronic wound biofilm model.</a> Advances in Wound Care. 4 (7), 382-388 (2015).</li><li>Bjarnsholt, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+in+vivo+biofilm.">The in vivo biofilm.</a> Trends in Microbiology. 21 (9), 466-474 (2013).</li><li>Stewart, P. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biophysics+of+biofilm+infection.">Biophysics of biofilm infection.</a> Pathogens and Disease. 70 (3), 212-218 (2014).</li><li>Jensen, L. K., Johansen, A. S. B., Jensen, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Porcine+models+of+biofilm+infections+with+focus+on+pathomorphology.">Porcine models of biofilm infections with focus on pathomorphology.</a> Frontiers in Microbiology. 8, 1961 (2017).</li><li>Mah, T. F., O'Toole, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+of+biofilm+resistance+to+antimicrobial+agents.">Mechanisms of biofilm resistance to antimicrobial agents.</a> Trends in Microbiology. 9 (1), 34-39 (2001).</li><li>Gonzalez, J. F., Hahn, M. M., Gunn, J. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+biofilm-based+infections:+Skewing+of+the+immune+response.">Chronic biofilm-based infections: Skewing of the immune response.</a> Pathogens and Disease. 76 (3), 023 (2018).</li><li>Roy, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mixed-species+biofilm+compromises+wound+healing+by+disrupting+epidermal+barrier+function.">Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function.</a> Journal of Pathology. 233 (4), 331-343 (2014).</li><li>Sen, C. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+wound+and+its+burden:+Updated+2020.">Human wound and its burden: Updated 2020.</a> Compendium of Estimates. Advances in Wound Care. 10 (5), 281-292 (2021).</li><li>Barki, K. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Electric+field+based+dressing+disrupts+mixed-species+bacterial+biofilm+infection+and+restores+functional+wound+healing.">Electric field based dressing disrupts mixed-species bacterial biofilm infection and restores functional wound healing.</a> Annals of Surgery. 269 (4), 756-766 (2019).</li><li>Dusane, D. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Electroceutical+treatment+of+Pseudomonas+aeruginosa+biofilms.">Electroceutical treatment of Pseudomonas aeruginosa biofilms.</a> Scientific Reports. 9 (1), 2008 (2019).</li><li>Roy, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Staphylococcus+aureus+biofilm+infection+compromises+wound+healing+by+causing+deficiencies+in+granulation+tissue+collagen.">Staphylococcus aureus biofilm infection compromises wound healing by causing deficiencies in granulation tissue collagen.</a> Annals of Surgery. 271 (6), 1174-1185 (2020).</li><li>Ghanbari, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inoculation+density+and+nutrient+level+determine+the+formation+of+mushroom-shaped+structures+in+Pseudomonas+aeruginosa+biofilms.">Inoculation density and nutrient level determine the formation of mushroom-shaped structures in Pseudomonas aeruginosa biofilms.</a> Scientific Reports. 6, 32097 (2016).</li><li>Yin, R., Cheng, J., Wang, J., Li, P., Lin, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Treatment+of+Pseudomonas+aeruginosa+infectious+biofilms:+Challenges+and+strategies.">Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies.</a> Frontiers in Microbiology. 13, 955286 (2022).</li><li>Norbury, W., Herndon, D. N., Tanksley, J., Jeschke, M. G., Finnerty, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Infection+in+burns.">Infection in burns.</a> Surgical Infections. 17 (2), 250-255 (2016).</li><li>Nitz, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+detection+of+drug-resistance+genes+of+bla(OXA-23)-bla(OXA-51)+and+mcr-1+in+clinical+isolates+of+Pseudomonas+aeruginosa.">Molecular detection of drug-resistance genes of bla(OXA-23)-bla(OXA-51) and mcr-1 in clinical isolates of Pseudomonas aeruginosa.</a> Microorganisms. 9 (4), 786 (2021).</li><li>Davis, S. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microscopic+and+physiologic+evidence+for+biofilm-associated+wound+colonization+in+vivo.">Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo.</a> Wound Repair and Regeneration. 16 (1), 23-29 (2008).</li><li>Breuing, K., Kaplan, S., Liu, P., Onderdonk, A. B., Eriksson, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Wound+fluid+bacterial+levels+exceed+tissue+bacterial+counts+in+controlled+porcine+partial-thickness+burn+infections.">Wound fluid bacterial levels exceed tissue bacterial counts in controlled porcine partial-thickness burn infections.</a> Plastic and Reconstructive Surgery. 111 (2), 781-788 (2003).</li><li>Nusbaum, A. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effective+method+to+remove+wound+bacteria:+Comparison+of+various+debridement+modalities+in+an+in+vivo+porcine+model.">Effective method to remove wound bacteria: Comparison of various debridement modalities in an in vivo porcine model.</a> Journal of Surgical Research. 176 (2), 701-707 (2012).</li><li>Hirsch, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhanced+susceptibility+to+infections+in+a+diabetic+wound+healing+model.">Enhanced susceptibility to infections in a diabetic wound healing model.</a> BMC Surgery. 8, 5 (2008).</li><li>Roche, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Increasing+the+presence+of+biofilm+and+healing+delay+in+a+porcine+model+of+MRSA-infected+wounds.">Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds.</a> Wound Repair and Regeneration. 20 (4), 537-543 (2012).</li><li>Hartoch, R. S., McManus, J. G., Knapp, S., Buettner, M. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Emergency+management+of+chronic+wounds.">Emergency management of chronic wounds.</a> Emergency Medical Clinics of North America. 25 (1), 203-221 (2007).</li><li>Mustoe, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Understanding+chronic+wounds:+a+unifying+hypothesis+on+their+pathogenesis+and+implications+for+therapy.">Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy.</a> American Journal of Surgery. 187 (5), 65-70 (2004).</li><li>Bhattacharya, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Staphylococcus+aureus+biofilms+release+leukocidins+to+elicit+extracellular+trap+formation+and+evade+neutrophil-mediated+killing.">Staphylococcus aureus biofilms release leukocidins to elicit extracellular trap formation and evade neutrophil-mediated killing.</a> Proceedings of the National Academy of Sciences of the United States of America. 115 (28), 7416-7421 (2018).</li><li>Chum, H., Pacharinsak, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Endotracheal+intubation+in+swine.">Endotracheal intubation in swine.</a> Lab Animal. 41 (11), 309-311 (2012).</li><li>Sinha, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pseudomonas+aeruginosa+theft+biofilm+require+host+lipids+of+cutaneous+wound.">Pseudomonas aeruginosa theft biofilm require host lipids of cutaneous wound.</a> Annals of Surgery. 277 (3), e634-e647 (2023).</li><li>Fan, G. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Severe+burn+injury+in+a+swine+model+for+clinical+dressing+assessment.">Severe burn injury in a swine model for clinical dressing assessment.</a> Journal of Visualized Experiments. (141), e57942 (2018).</li><li>Sullivan, T. P., Eaglstein, W. H., Davis, S. C., Mertz, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+pig+as+a+model+for+human+wound+healing.">The pig as a model for human wound healing.</a> Wound Repair and Regeneration. 9 (2), 66-76 (2001).</li><li>Meyer, W., Schwarz, R., Neurand, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+skin+of+domestic+mammals+as+a+model+for+the+human+skin,+with+special+reference+to+the+domestic+pig.">The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig.</a> Current Problems in Dermatology. 7, 39-52 (1978).</li><li>Vardaxis, N. J., Brans, T. A., Boon, M. E., Kreis, R. W., Marres, L. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Confocal+laser+scanning+microscopy+of+porcine+skin:+implications+for+human+wound+healing+studies.">Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies.</a> Journal of Anatomy. 190, 601-611 (1997).</li><li>Heinrich, W., Lange, P. M., Stirtz, T., Iancu, C., Heidemann, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Isolation+and+characterization+of+the+large+cyanogen+bromide+peptides+from+the+alpha1-+and+alpha2-chains+of+pig+skin+collagen.">Isolation and characterization of the large cyanogen bromide peptides from the alpha1- and alpha2-chains of pig skin collagen.</a> FEBS Letters. 16 (1), 63-67 (1971).</li><li>Marcarian, H. Q., Calhoun, M. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microscopic+anatomy+of+the+integument+of+adult+swine.">Microscopic anatomy of the integument of adult swine.</a> American Journal of Veterinary Research. 27 (118), 765-772 (1966).</li><li>Sullivan, T. P., Eaglstein, W. H., Davis, S. C., Mertz, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+pig+as+a+model+for+human+wound+healing.">The pig as a model for human wound healing.</a> Wound Repair and Regeneration. 9 (2), 66-76 (2001).</li><li>Dawson, H. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structural+and+functional+annotation+of+the+porcine+immunome.">Structural and functional annotation of the porcine immunome.</a> BMC Genomics. 14, 332 (2013).</li><li>Kim, J. Y., Dunham, D. M., Supp, D. M., Sen, C. K., Powell, H. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Novel+burn+device+for+rapid,+reproducible+burn+wound+generation.">Novel burn device for rapid, reproducible burn wound generation.</a> Burns. 42 (2), 384-391 (2016).</li><li>Nielson, C. B., Duethman, N. C., Howard, J. M., Moncure, M., Wood, J. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Burns:+Pathophysiology+of+systemic+complications+and+current+management.">Burns: Pathophysiology of systemic complications and current management.</a> Journal of Burn Care and Research. 38 (1), e469-e481 (2017).</li><li>Rowan, M. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Burn+wound+healing+and+treatment:+Review+and+advancements.">Burn wound healing and treatment: Review and advancements.</a> Critical Care. 19 (1), 243 (2015).</li></ol>

The authors declare no competing interests.

This report provides a detailed protocol for setting up a swine model of chronic wound biofilm infection for experimental studies. Several swine biofilm models have been reported previously22,23,24,25,26, but none of them are swine models involving 8 week long-term studies. Chronic wounds are those that remain open for 4 weeks or more14,27,28. There are no other chronic wound biofilm models reported in the literature. This work addresses the notion of functional wound closure2,7,13,15,17,29. A study conducted in 2014 was the first to report that biofilm-infected wounds may close without the restoration of barrier function7. The measurement of the skin barrier function in the healing wound using transepidermal water loss (TEWL) is reported in this work.
Anatomically and physiologically, the porcine skin, compared to the skin of other small animals, is a closer match to the human skin32,33,34. Both pig and human skin has a thick epidermis33, and the dermal-epidermal thickness ratio ranges from 10:1 to 13:1 in pig, which is comparable to humans34,35. Histologically and biomechanically, the skin of humans and pigs shows similarities in the rete-ridges, subdermal fat, dermal collagen, hair distribution, adnexal structures, and blood vessel size and distribution36,37,38. Functionally, both pigs and humans share similarities in the composition of the lipid, protein, and keratin components of the epidermal layer, as well as comparable immunohistological patterns37,38. The porcine immune system, compared to that of other small animals, shares higher similarities with the human immune system, meaning pigs are an appropriate model for studies on the host interactions that are integral to the complexities of the pathological biofilm in wound infections39. The critical assessment of the pros and cons offered by various animal models has led to the consensus that pigs represent an efficient model for studying wound healing34,38. Additionally, domestic pigs spontaneously develop chronic bacterial infections, as observed in humans10. The burn device used to create the wounds is an advanced and automated burn device that delivers heat energy based on a temperature read out from the targeted skin site22,40. Such an approach improves the rigor and reproducibility of the burn injury. The use of human clinical isolates of bacteria to infect the pig wounds adds value as a pre-clinical model.
Burn injuries are complex and cause several systemic perturbations20,41. Thus, it is important to resuscitate the pig with adequate fluids and prevent hypothermia during anesthesia and recovery. Several factors can interfere with the wound healing, including the post-burn nutrition, fluids, and pain42. Close monitoring of the nutrition and pain assessments is, therefore, of importance. Post-burn pain can be severe and influence the animal&#39;s behavior and diet. Interventions to address behavioral concerns must be actively considered. Regular and continuous pain scoring and management is imperative. A thorough pain assessment sheet with a very detailed pain management plan is included in this protocol. To avoid cross-contamination between the wounds, special attention should be made to apply the first layer of the dressing on each wound separately. Critical care should be taken in handling all the biohazardous materials and when performing the thorough disinfection of the equipment, tools, and entire surgical room. The application of multiple layers of the dressing prevents the pig from exposing the wounds during their effort to rub or scratch the itching back.
The pig in the current model was not compromised by underlying metabolic disorders (e.g., diabetes), and, therefore, the effect being studied was purely the impact of the bacterial biofilm infection on wound healing. However, the model lends itself to the induction of diabetes (using streptozotocin for example) and could be used to study biofilm infection in relation to an underlying metabolic disorder. The other limitation of the model is the controlled infection setting using P. aeruginosa, a bacterium. It is expected that the normal skin micro-flora of the pig may also be growing in the wound and could impact healing. Further analysis using NGS or other advanced techniques to delineate the microbial content of the wound is necessary. The current model could also be applied to mixed infections with differing microbial species (e.g., fungal, viral, etc.). This is an important element, as clinically relevant wounds are likely to be populated by mixed microbes, which may impact wound healing differentially.
There are many potential advantages in this model, including the similarity to the complexity and long-term sequelae of human chronic wounds, the automated and reproducible burn process, and the use of clinically isolated bacterial species. The use of multiple non-invasive imaging modalities represents a powerful approach for collecting useful physiological data characterizing the wound. Finally, the assessment of the functional wound healing via the restoration of skin barrier function based on TEWL is critical. In conclusion, a robust, simple, detailed, and easy-to-use protocol to develop a biofilm-infected severe burn injury using a porcine model system is shown in this work.

Biofilm infection complicates burn and chronic wounds and causes chronicity1,2,3,4,5. In microbiology, biofilm mechanisms are primarily studied, with a focus on the microbes1,6. The lessons learned from these studies are of paramount importance from a biological science standpoint but may not necessarily be applicable to clinically relevant pathogenic biofilms6,7,8. Clinically relevant biofilm structural aggregates should include microbial as well as host factors8,9,10. Such a microenvironment allows for the inclusion of host-microbe iterative interactions, which are critical to developing a clinically relevant biofilm7,8. In such a process, the participation of immune cells and blood-borne factors is critical11,12. The host-microbe interactions underlying clinical pathogenic biofilms, as seen in chronic wounds, occur over a long period of time. Thus, any experimental approach aimed at developing a translationally relevant model of biofilm infection must account for these factors. So, we sought to develop a clinically reproducible swine chronic biofilm infection model.
While human studies clearly represent the best approach to studying healing outcomes, often they are not best suited to addressing the underlying mechanisms and new mechanistic paradigms. Ethical concerns limit the use of study designs requiring the collection of multiple biopsies from a chronic wound at different time points. It is, therefore, critical to have a well-established and reproducible animal model to enable invasive studies for the thorough examination of biofilm fate7,13. The selection of an animal model depends on several factors, including scientific/translational relevance and logistics. The porcine system is widely acknowledged to be the most translationally valuable experimental model to study human skin wounds7. Thus, this work reports an established swine model of biofilm-infected full-thickness burn injury. This work is based on several original publications reported in the literature2,7,13,14,15,16,17. In this study, a clinical isolate of multidrug-resistant&#160;Pseudomonas aeruginosa (PA01) was chosen to infect the wound. P. aeruginosa is a common cause of wound infections2,18,19,20. It is a Gram-negative bacterium that can be difficult to treat due to its resistance to some antibiotics11,19,21. None of the swine biofilm models reported so far involved 8 week long-term studies22,23,24,25,26. Chronic wounds are those that remain open for 4 weeks or more14,27,28. There are no other chronic wound biofilm models reported in the literature. This work addresses the notion of functional wound closure2,7,13,15,17,29.

<table><tbody><tr><td>&lt;strong&gt;Sedation&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Ketamine</td><td>Zoetis</td><td>10004027</td><td>100mg/ml</td></tr><tr><td>Telazol</td><td>Zoetis</td><td>106-111</td><td>100mg/ml</td></tr><tr><td>Xylazine</td><td>Pivetal</td><td>04606-6750-02</td><td>100mg/ml Anased</td></tr><tr><td>3ml syringe w/ 20g needle</td><td>Covidien-Monoject</td><td>8881513033</td><td></td></tr><tr><td>Winged infusion set 21g</td><td>Jorgensen Labs</td><td>J0454B</td><td></td></tr><tr><td>&lt;strong&gt;Anesthetic&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Isoflurane</td><td>Pivetal</td><td>21295097</td><td></td></tr><tr><td>&lt;strong&gt;Surgery&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Hair clippers</td><td>Wahl</td><td>8787-450A</td><td></td></tr><tr><td>Nair</td><td>Church and Dwight Co. Inc</td><td>70506572</td><td></td></tr><tr><td>Chlorhexidine Solution</td><td>First Priority Inc.</td><td>179925722</td><td></td></tr><tr><td>70% Isopropyl Alcohol</td><td>Uline</td><td>S-17474</td><td></td></tr><tr><td>0.9% Saline Solution</td><td>ICU Medical</td><td>&amp;nbsp;RL-7282</td><td></td></tr><tr><td>Non-woven gauze</td><td>Pivetal</td><td>21295051</td><td></td></tr><tr><td>Paper tape</td><td>McKesson</td><td>455531</td><td></td></tr><tr><td>2&quot; Elastic tape</td><td>Pivetal</td><td>21300869</td><td></td></tr><tr><td>18-22g Intravenous Angiocath</td><td>SurVet</td><td>(01)14806017512306</td><td></td></tr><tr><td>Spay hook</td><td>Jorgensen Labs</td><td>J0112A</td><td></td></tr><tr><td>Sterile lube</td><td>McKesson</td><td>16-8942</td><td></td></tr><tr><td>Laryngoscope</td><td>Jorgensen Labs</td><td>J0449S</td><td></td></tr><tr><td>Roll gauze</td><td>Pivetal</td><td>21295032</td><td></td></tr><tr><td>Endotracheal tube (7-9mm)</td><td>Covidien</td><td>86112</td><td>Shiley Hi-Lo Oral Nasal Tracheal Tube Cuffed</td></tr><tr><td>15gtt/ml IV administration set</td><td>ICU Medical</td><td>12672-28</td><td></td></tr><tr><td>LRS 1000ml bag</td><td>ICU Medical</td><td>07953-09</td><td></td></tr><tr><td>Three Quarter Drape Sheet</td><td>McKesson</td><td>16-i80-12110G</td><td></td></tr><tr><td>&lt;strong&gt;Analgesia&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Buprenorphine</td><td>RX Generics</td><td>42023-0179-05</td><td>0.3mg/ml</td></tr><tr><td>Fentanyl Transdermal</td><td></td><td></td><td></td></tr><tr><td>Carprofen</td><td>21294548</td><td>Pivetal</td><td>50mg/ml Levafen</td></tr><tr><td>&lt;strong&gt;Bandaging&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Transparent film dressing 26x30</td><td>Genadyne Biotechnologies</td><td>A4-S00F5</td><td></td></tr><tr><td>Film dressing 4 x 4-3/4 Frame Style</td><td>McKesson</td><td>886408</td><td></td></tr><tr><td>Vetrap</td><td>3M</td><td>1410BK BULK</td><td></td></tr><tr><td>Elastic tape 4&quot;</td><td>Pivetal</td><td>21300931</td><td></td></tr><tr><td>Kerlix Roll Gauze</td><td>Cardinal Health</td><td>3324</td><td></td></tr><tr><td>&lt;strong&gt;Imaging&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Canon EOS 80D</td><td>Canon</td><td>1263C004</td><td></td></tr><tr><td>Speedlight 600EX II-RT</td><td>Canon</td><td>1177C002</td><td></td></tr><tr><td>EFS 17-55mm Ultrasonic</td><td>Canon</td><td>1242B002</td><td></td></tr><tr><td>GE Logiq E9</td><td>GE</td><td>5197104-2</td><td></td></tr><tr><td>ML6-15 Probe</td><td>GE</td><td>5199103</td><td></td></tr><tr><td>PeriCamPSI</td><td>Perimed</td><td>90-00070</td><td></td></tr><tr><td>DermaLab</td><td>Cortex Technologies Inc</td><td>4608D78</td><td></td></tr><tr><td>&lt;strong&gt;Biopsy/Tissue Collection&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>6mm punch biopsy</td><td>Integra Lifesciences</td><td>33-36</td><td></td></tr><tr><td>bupivicaine 0.5%</td><td>Auromedics Pharma</td><td>55150017030</td><td></td></tr><tr><td>Size 10 Disposable Scalpel</td><td>McKesson</td><td>16-63810</td><td></td></tr><tr><td>Dissection scissors</td><td>Pivetal</td><td>21294806</td><td></td></tr><tr><td>Rat tooth thumb tissue forceps</td><td>Aesculap</td><td>BD512R</td><td></td></tr><tr><td>Non-adherent Dressing</td><td>Covidien</td><td>2132</td><td>Telfa</td></tr><tr><td>50ml Conical tube</td><td>Falcon</td><td>352070</td><td></td></tr><tr><td>Eppendorf/microcentrifuge tube</td><td>Fisherbrand</td><td>02-681-320</td><td></td></tr><tr><td>OCT Cassette</td><td></td><td></td><td></td></tr><tr><td>Non Woven Gauze 4x4</td><td>Pivetal</td><td>21295051</td><td></td></tr><tr><td>&lt;strong&gt;Inoculum&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Low salt LB agar</td><td>Invitrogen</td><td>22700-025</td><td></td></tr><tr><td>Low salt LB broth</td><td>Fisher scientific</td><td>BP1427-500</td><td></td></tr><tr><td>Petri plate</td><td>Falcon</td><td>REF-351029</td><td></td></tr><tr><td>Polyprophyline round bottom tubes (14 ml)</td><td>Falcon</td><td>REF-352059</td><td></td></tr><tr><td>Pseudomonas Agar Base (Dehydrated)</td><td>Thermo Scientific</td><td>OXCM0559B</td><td></td></tr><tr><td>LB Agar, powder (Lennox L agar)</td><td>Thermo Fisher Scientific (Life Technologies)</td><td>22700025</td><td></td></tr><tr><td>Gibco&amp;trade; DPBS, calcium, magnesium</td><td>Gibco</td><td>14040133</td><td></td></tr><tr><td>&lt;strong&gt;Euthanasia&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>18-22g Intravenous Angiocath</td><td>SurVet</td><td>(01)14806017512306</td><td></td></tr><tr><td>Fatal Plus</td><td>Vortech Pharmaceuticals</td><td>9373</td><td></td></tr></tbody></table>

swine model of biofilm infection and invisible wounds

Biofilm infection is a major contributor to wound chronicity. The establishment of clinically relevant experimental wound biofilm infection requires the involvement of the host immune system. Iterative changes in the host and pathogen during the formation of such clinically relevant biofilm can only occur in vivo. The swine wound model is recognized for its advantages as a powerful pre-clinical model. There are several reported approaches for studying wound biofilms. In vitro and ex vivo systems are deficient in terms of the host immune response. Short-term in vivo studies involve acute responses and, thus, do not allow for biofilm maturation, as is known to occur clinically. The first long-term swine wound biofilm study was reported in 2014. The study recognized that biofilm-infected wounds may close as determined by planimetry, but the skin barrier function of the affected site may fail to be restored. Later, this observation was validated clinically. The concept of functional wound closure was thus born. Wounds closed but deficient in skin barrier function may be viewed as invisible wounds. In this work, we seek to report the methodological details necessary to reproduce the long-term swine model of biofilm-infected severe burn injury, which is clinically relevant and has translational value. This protocol provides detailed guidance on establishing an 8 week wound biofilm infection using P. aeruginosa (PA01). Eight full-thickness burn wounds were created symmetrically on the dorsum of domestic white pigs, which were inoculated with (PA01) at day 3 post-burn; subsequently, noninvasive assessments of the wound healing were conducted at different time points using laser speckle imaging (LSI), high-resolution ultrasound (HUSD), and transepidermal water loss (TEWL). The inoculated burn wounds were covered with a four-layer dressing. Biofilms, as established and confirmed structurally by SEM at day 7 post-inoculation, compromised the functional wound closure. Such an adverse outcome is subject to reversal in response to appropriate interventions.

A standardized burn device was used to create full-thickness burn wounds at 150 &#176;C for 1 min, which resulted in a homogenous deep burn with a uniform margin of erythema and inflammation (Figure 3 and Figure 7). Each pig received eight full-thickness burn wounds on their back, as depicted in Figure 3C. 
The non-invasive real-time assessment of the burn wounds by B-mode high-resolution ultrasound to confirm the wound depth and progression of wound healing over time showed the destruction of all skin layers up to the subcutaneous fat (Figure 4). Laser speckle imaging (LSI) was used for further characterization of the wound perfusion (Figure 4A).
The burn wounds showed a thick pyogenic membrane on the wound surface by day 7 post-inoculation, thus confirming the infection and the establishment of the burn wound biofilm (Figure 7A). Digital planimetry showed an increased wound area at day 3 post-inoculation with PAO1 due to the inflammatory response at the wound site and margins (Figure 7A,B). Although the wound area started to shrink by day 14 post-inoculation, incomplete healing to approximately 25% of the original wound size was observed at day 56, indicating the chronicity of the wounds (Figure 7B). Wound chronicity and impaired wound healing were further confirmed by the TEWL, which showed high transepidermal water loss. The TEWL results reflected the loss of skin barrier function compared to normal skin at all measured the timepoints, thus indicating functional impairment of the burn wound healing (Figure 7B). This was also confirmed by the suppression of the tight junctional proteins ZO-1 and 213 and the impairment of the restoration of skin barrier function, as reflected in the high TEWL values seen at day 35 (mid) and day 56 (late) despite the visual wound closure (Figure 7I).
The burn depth was further validated by H&#38;E staining, which showed distortion and necrosis of all the histological skin layers, as shown in Figure 7C. The established biofilm of PA01 was further validated at day 7 post-inoculation by CFU (Figure 7E,F), SEM imaging (Figure 7G), and immunofluorescence staining (Figure 7H).
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/65301/65301fig01.jpg" /> 
Figure 1: Setup for the procedure. (A) Surgical table preparation. (B) Ear vein cannulation for IV fluids and drug administration. (C)&#160;Thermal blanket covering to protect the pig from hypothermia during the procedure. (D) Burner and timer setup. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/65301/65301fig02.jpg" /> 
Figure 2: Surgical site sterilization and marking. (A) Hair clipping and sterilization. (B) Marking of the burn site using a sterile eight-wound standard template (each wound is 2 in x 2 in). (C)&#160;Final marking using a sterile skin marker. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig02large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/65301/65301fig03.jpg" /> 
Figure 3: Burn wound induction. (A,B) Standardized burner with a pressure gauge and automated controller unit (2 in x 2 in) applied to the pre-marked wound site. (C)&#160;The whole back showing the eight full-thickness burn wounds. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig03large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 4" class="xfigimg" src="/files/ftp_upload/65301/65301fig04.jpg" /> 
Figure 4: Noninvasive burn wound imaging and assessment. (A) Laser speckle imaging (LSI) with proper orientation of the laser beam indicator to the center of the wound is shown in the left-side image; the right-side image shows the LSI device and the real-time skin vascular perfusion map. (B) Transepidermal water loss (TEWL) probe application to the wound site at five different spots (four wound corners and the center demonstrated in lower-right corner image) is shown in the left-side image; the right-side image is a representative real-time captured screen of the TEWL measurement. (C) Harmonic ultrasound scanning of the burn wound using a high-resolution 16 MHz ultrasound probe is shown on the left side; the right-side image shows the ultrasound device and the real-time screen recording. (D) Structural (B-mode images, grayscale ultrasound) and biomechanical (elastography, color ultrasound) images of the burn wound site at the inoculation day and day 7 post-inoculation. The wound depth is indicated by the yellow dashed line. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig04large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 5" class="xfigimg" src="/files/ftp_upload/65301/65301fig05.jpg" /> 
Figure 5: Wound dressing and bandaging. (A) Application of the transparent film dressing for each wound separately. (B)&#160;All the dorsal inoculated burn wounds are covered with the first layer of dressing. (C)&#160;A larger transparent film dressing is placed over the entire wound area.(D)&#160;Application of the second layer of gauze and a loose layer of stretchy elastic bandage around the entire trunk of the pig to absorb any fluid exudate that comes from the wounds. (E)&#160;Covering of the entire wound area with a final layer of 4 in adhesive dressing. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig05large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 6" class="xfigimg" src="/files/ftp_upload/65301/65301fig06.jpg" /> 
Figure 6: Bacterial inoculation. (A) Setup for the Pseudomonas aeruginosa (PA01) inoculation at day 3 post-burn. (B)&#160;Topical application of the inoculum with a pipette using a 500 &#181;L volume for each wound. (C)&#160;The inoculum is dispersed across the wound surface evenly using a sterile disposable spreader. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig06large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 7" class="xfigimg" src="/files/ftp_upload/65301/65301fig07.jpg" /> 
Figure 7: Wound healing progress and biofilm confirmation. (A) Representative images of the wound closure over the timeline of the study. Scale bar = 1 cm. (B) Quantitation of the wound area and TEWL measurements over the timeline of the study (n = 6). The data are represented as mean &#177; SD. N.S. refers to the TEWL value of normal skin. (C)&#160;Schematic diagram showing different wound biopsy sites. D. H&#38;E staining with its corresponding Masson&#39;s trichrome staining showing distortion and necrosis of all the skin layers at day 3 post-burn and day 7 post-inoculation. Scale bar = 500 &#181;m. (E) Representative digital images of non-selective agar (Luria-Bertani agar) and selective agar (Pseudomonas Isolation Agar) with bacterial colonies grown from porcine wound bed tissue. The selective medium enables the accurate counting of the PA01 colonies only. (F) A sample colony forming unit (CFU) calculation from the colony counts taken from processed day 7 post-inoculation wound biopsies is shown. (G) Representative scanning electron microscopy (SEM) images of the inoculated burn wounds at day 7 post-inoculation showing the established PA01 biofilm, with a zoomed-in image on the right side. Scale bar = 1 &#181;m. The red arrowheads point to extracellular polymeric substances (EPS). (H) P. aeruginosa on the burn wounds were visualized using anti-Pseudomonas (green) antibody; the immunofluorescence images of the day 7 post-inoculation wound biopsies show heavy colonization of the wound tissues by P. aeruginosa. Scale bar = 100 &#181;m.&#160;(I) Representative mosaic (scale bar = 200 &#181;m) and corresponding zoomed-in (scale bar = 50 &#181;m) images of ZO-1- and ZO-2-stained sections on day 35 and day 56 post-inoculation, demonstrating reduced expression of the proteins following the induced infection. The OCT-embedded frozen sections (10 &#181;m) were stained using anti-ZO-1 (green) or anti-ZO-2 (green). The sections were counterstained using DAPI. The bar graphs present the quantitation of the ZO-1 and ZO-2 signal intensity. The data are presented as mean &#177; SD (n = 3); * p &#60; 0.05 compared to spontaneous ones. Mann-Whitney or Kruskal-Wallis one-way analysis of variance tests were performed to test the significance. Figure 7H,I has been modified from Roy et al.13. <a href="https://jove.unicartagenaproxy.elogim.com/files/ftp_upload/65301/65301fig07large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>

Watch this Scientific Journal Video about Studying Host-Microbe Interactions in Wound Biofilm Formation at JoVE.com

Author Spotlight: Studying Host-Microbe Interactions in Wound Biofilm Formation 

Chronic wounds that are resistant to antibiotics are a major threat to the healthcare system. Biofilm infections are stubborn and hostile and can cause deficient functional wound closure. We report a clinically relevant swine model of biofilm-infected full-thickness chronic wounds. This model is powerful for mechanistic studies as well as for testing interventions.

Swine Model of Biofilm Infection and Invisible Wounds

Biofilm infection is a major contributor to wound chronicity. The establishment of clinically relevant experimental wound biofilm infection requires the ...

swine-model-of-biofilm-infection-and-invisible-wounds

Universidad de Cartagena UDEC

Research

JoVE Journal

Immunology and Infection

1.8K Views.  Indiana University School of Medicine. Chronic wounds that are resistant to antibiotics are a major threat to the healthcare system. Biofilm infections are stubborn and hostile and can cause deficient functional wound closure. We report a clinically relevant swine model of biofilm-infected full-thickness chronic wounds. This model is powerful for mechanistic studies as well as for testing interventions.

Video: Author Spotlight: Studying Host-Microbe Interactions in Wound Biofilm Formation 

Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells

Many microbial cells have the ability to form sessile microbial communities defined as biofilms that have altered physiological and pathological properties compared to free living microorganisms. Biofilms in nature are often difficult to investigate and reside under poorly defined conditions1. Using a transparent substratum it is possible to device a system where simple biofilms can be examined in a non-destructive way in real-time: here we demonstrate the assembly and operation of a flow cell model system, for in vitro 3D studies of microbial biofilms generating high reproducibility under well-defined conditions2,3.
The system consists of a flow cell that serves as growth chamber for the biofilm. The flow cell is supplied with nutrients and oxygen from a medium flask via a peristaltic pump and spent medium is collected in a waste container. This construction of the flow system allows a continuous supply of nutrients and administration of e.g. antibiotics with minimal disturbance of the cells grown in the flow chamber. Moreover, the flow conditions within the flow cell allow studies of biofilm exposed to shear stress. A bubble trapping device confines air bubbles from the tubing which otherwise could disrupt the biofilm structure in the flow cell.
The flow cell system is compatible with Confocal Laser Scanning Microscopy (CLSM) and can thereby provide highly detailed 3D information about developing microbial biofilms. Cells in the biofilm can be labeled with fluorescent probes or proteins compatible with CLSM analysis. This enables online visualization and allows investigation of niches in the developing biofilm. Microbial interrelationship, investigation of antimicrobial agents or the expression of specific genes, are of the many experimental setups that can be investigated in the flow cell system.

Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells

Protocol describing the application of a flow cell system for growing and analyzing microbial biofilms for Confocal Laser Scanning Microscopy (CLSM).

Many microbial cells have the ability to form sessile microbial communities defined as biofilms that have altered physiological and pathological ...

Microtiter Dish Biofilm Formation Assay

Biofilms are communities of microbes attached to surfaces, which can be found in medical, industrial and natural settings. In fact, life in a biofilm probably represents the predominate mode of growth for microbes in most environments. Mature biofilms have a few distinct characteristics. Biofilm microbes are typically surrounded by an extracellular matrix that provides structure and protection to the community. Microbes growing in a biofilm also have a characteristic architecture generally comprised of macrocolonies (containing thousands of cells) surrounded by fluid-filled channels. Biofilm-grown microbes are also notorious for their resistance to a range of antimicrobial agents including clinically relevant antibiotics.
The microtiter dish assay is an important tool for the study of the early stages in biofilm formation, and has been applied primarily for the study of bacterial biofilms, although this assay has also been used to study fungal biofilm formation. Because this assay uses static, batch-growth conditions, it does not allow for the formation of the mature biofilms typically associated with flow cell systems. However, the assay has been effective at identifying many factors required for initiation of biofilm formation (i.e, flagella, pili, adhesins, enzymes involved in cyclic-di-GMP binding and metabolism) and well as genes involved in extracellular polysaccharide production. Furthermore, published work indicates that biofilms grown in microtiter dishes do develop some properties of mature biofilms, such a antibiotic tolerance and resistance to immune system effectors.
This simple microtiter dish assay allows for the formation of a biofilm on the wall and/or bottom of a microtiter dish. The high throughput nature of the assay makes it useful for genetic screens, as well as testing biofilm formation by multiple strains under various growth conditions. Variants of this assay have been used to assess early biofilm formation for a wide variety of microbes, including but not limited to, pseudomonads, Vibrio cholerae, Escherichia coli, staphylocci, enterococci, mycobacteria and fungi.
In the protocol described here, we will focus on the use of this assay to study biofilm formation by the model organism Pseudomonas aeruginosa. In this assay, the extent of biofilm formation is measured using the dye crystal violet (CV). However, a number of other colorimetric and metabolic stains have been reported for the quantification of biofilm formation using the microtiter plate assay. The ease, low cost and flexibility of the microtiter plate assay has made it a critical tool for the study of biofilms.

The assay describes a rapid means to measure early biofilm formation in bacteria and fungi. This method uses a microtiter plate as the substratum for microbial biofilm formation, and the biofilm is visualized using crystal violet strain. The assay provides either a qualitative or quantitative assay for early biofilm formation.

Biofilms are communities of microbes attached to surfaces, which can be found in medical, industrial and natural settings.  In fact, life in a biofilm ...

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

The presence of bacteria as structured biofilms in chronic wounds, especially in diabetic patients, is thought to prevent wound healing and resolution. Chronic mouse wounds models have been used to understand the underlying interactions between the microorganisms and the host. The models developed to date rely on the use of haired animals and terminal collection of wound tissue for determination of viable bacteria. While significant insight has been gained with these models, this experimental procedure requires a large number of animals and sampling is time consuming. We have developed a novel murine model that incorporates several optimal innovations to evaluate biofilm progression in chronic wounds: a) it utilizes hairless mice, eliminating the need for hair removal; b) applies pre-formed biofilms to the wounds allowing for the immediate evaluation of persistence and effect of these communities on host; c) monitors biofilm progression by quantifying light production by a genetically engineered bioluminescent strain of Pseudomonas aeruginosa, allowing real-time monitoring of the infection thus reducing the number of animals required per study. In this model, a single full-depth wound is produced on the back of STZ-induced diabetic hairless mice and inoculated with biofilms of the P. aeruginosa bioluminescent strain Xen 41. Light output from the wounds is recorded daily in an in vivo imaging system, allowing for in vivo and in situ rapid biofilm visualization and localization of biofilm bacteria within the wounds. This novel method is flexible as it can be used to study other microorganisms, including genetically engineered species and multi-species biofilms, and may be of special value in testing anti-biofilm strategies including antimicrobial occlusive dressings.

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

Here we describe a novel diabetic murine model utilizing hairless mice for real-time, non-invasive, monitoring of biofilm wound infections of bioluminescent Pseudomonas aeruginosa. This method can be adapted to evaluate infection of other bacterial species and genetically modified microorganisms, including multi-species biofilms, and test the efficacy of antibiofilm strategies.

The presence of bacteria as structured biofilms in chronic wounds, especially in diabetic patients, is thought to prevent wound healing and resolution. ...

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of chronic wound infections in diabetic and hospitalized patients. There is an urgent need for chronic infection models to aid in the investigation of wound pathogenesis and the development of new therapies against this pathogen. Here, we describe a protocol that uses delayed inoculation 24 hours after full-thickness excisional wounding. The infection of the provisional wound matrix present at this time forestalls either rapid clearance or dissemination of infection and instead establishes chronic infection lasting 7&#8211;10 days without the need for implantation of foreign materials or immune suppression. This protocol mimics a typical temporal course of post-operative infection in humans. The use of a luminescent P. aeruginosa strain (PAO1:lux) allows for quantitative daily assessment of bacterial burden for P. aeruginosa wound infections. This novel model may be a useful tool in the investigation of bacterial pathogenesis and the development of new therapies for chronic P. aeruginosa wound infections.

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

We describe a delayed inoculation protocol for generating chronic wound infections in immunocompetent mice.

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of ...

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Wound healing is a complex process that requires the orderly progression of inflammation, granulation tissue formation, fibrosis, and resolution. Murine models provide valuable mechanistic insight into these processes; however, no single model fully addresses all aspects of the wound healing response. Instead, it is ideal to use multiple models to address the different aspects of wound healing. Here, two different methods that address diverse aspects of the wound healing response are described. In the first model, polyvinyl alcohol sponges are subcutaneously implanted along the mouse dorsum. Following sponge retrieval, cells can be isolated by mechanical disruption, and fluids can be extracted by centrifugation, thus allowing for a detailed characterization of cellular and cytokine responses in the acute wound environment. A limitation of this model is the inability to assess the rate of wound closure. For this, a tail skin excision model is utilized. In this model, a 10 mm x 3 mm rectangular piece of tail skin is excised along the dorsal surface, near the base of the tail. This model can be easily photographed for planimetric analysis to determine healing rates and can be excised for histological analysis. Both described methods can be utilized in genetically altered mouse strains, or in conjunction with models of comorbid conditions, such as diabetes, aging, or secondary infection, in order to elucidate wound healing mechanisms.

Here, two murine wound healing models are described, one designed to assess cellular and cytokine wound healing responses and the other to quantify the rate of wound closure. These methods can be used with complex disease models such as diabetes to determine mechanisms of various aspects of poor wound healing.

Wound healing is a complex process that requires the orderly progression of inflammation, granulation tissue formation, fibrosis, and resolution. Murine ...

Protocol to Create Chronic Wounds in Diabetic Mice

Chronic wounds develop as a result of defective regulation in one or more complex cellular and molecular processes involved in proper healing. They impact ~6.5M people and cost ~$40B/year in the US alone. Although a significant effort has been invested in understanding how chronic wounds develop in humans, fundamental questions remain unanswered. Recently, we developed a novel mouse model for diabetic chronic wounds that have many characteristics of human chronic wounds. Using db/db-/- mice, we can generate chronic wounds by inducing high levels of oxidative stress (OS) in the wound tissue immediately after wounding, using a one-time treatment with inhibitors specific to the antioxidant enzymes catalase and glutathione peroxidase. These wounds have high levels of OS, develop biofilm naturally, become fully chronic within 20 days after treatment and can remain open more for more than 60 days. This novel model has many features of diabetic chronic wounds in humans and therefore can contribute significantly to advancing fundamental understanding of how wounds become chronic. This is a major breakthrough because chronic wounds in humans cause significant pain and distress to patients and result in amputation if unresolved. Moreover, these wounds are very expensive and time-consuming to treat, and lead to significant loss of personal income to patients. Advancements in this field of study through the use of our chronic wound model can significantly improve health care for millions who suffer under this debilitating condition. In this protocol, we describe in great detail the procedure to cause acute wounds to become chronic, which has not been done before.

Chronic wounds are developed from acute wounds on a diabetic mouse model by inducing high levels of oxidative stress after a full-thickness cutaneous wound. The wound is treated with inhibitors for catalase and glutathione peroxidase, resulting in impaired healing and biofilm development by bacteria present in the skin microbiome.

Chronic wounds develop as a result of defective regulation in one or more complex cellular and molecular processes involved in proper healing. They impact ...

Medicine

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Wound healing is a dynamic repair process and is the most complex biological process in human life. In response to burn injury, alterations in biological pathways impair the inflammation response, resulting in delayed wound healing. Impaired wound healing frequently occurs in patients with diabetes leading to unfavorable outcomes such as amputation. Hence, dressings having beneficial effect in promoting burn wound repair are needed. However, studies on burn wound treatment are limited due to lack of proper animal models. Our previous study demonstrated wound-healing performance in rat and swine models using a minimally invasive surgical technique. This study aimed to demonstrate a swine model of severe burn injury that eliminates wound contraction and more closely approximates the human processes of re-epithelialization and new tissue formation. This protocol provides a detailed procedure for creating consistent burn wounds and examining the wound-healing performance under the treatment of an experimental dressing in a swine model. Six burn wounds were created symmetrically on the dorsum, which were covered with a clinical dressing composed of four layers: an inner contact layer of experimental materials, an inner intermediate layer of waterproof film, an outer intermediate layer of gauze, and an outer layer of adhesive plaster. Upon the completion of experiments, wound closure, wound area, and Vancouver Scar Scale score were examined. The samples of skin resected from each animal post-sacrifice were histologically prepared and stained using hematoxylin and eosin staining. Antibacterial activity of each dressing in the context of wound healing was also examined. The application of the clinical dressing to the wounds in swine model mimics the biological processes of human wound healing with respect to the processes of epithelialization, cellular proliferation, and angiogenesis. Therefore, this swine model provides an easy-to-learn, cost-effective, and robust method to assess the effect of clinical dressings in severe burn injury.

To closely mimic the mode of burn injuries requires the interplay between clinical observation and studies in animal models. In this study, a swine model of severe burn injury was established to assess an experimental dressing in physiological and pathophysiological settings.

Wound healing is a dynamic repair process and is the most complex biological process in human life. In response to burn injury, alterations in biological ...

Assessing Biofilm Dispersal in Murine Wounds

Biofilm-related infections are implicated in a wide array of chronic conditions such as non-healing diabetic foot ulcers, chronic sinusitis, reoccurring otitis media, and many more. Microbial cells within these infections are protected by an extracellular polymeric substance (EPS), which can prevent antibiotics and host immune cells from clearing the infection. To overcome this obstacle, investigators have begun developing dispersal agents as potential therapeutics. These agents target various components within the biofilm EPS, weakening the structure, and initiating dispersal of the bacteria, which can theoretically improve antibiotic potency and immune clearance. To determine the efficacy of dispersal agents for wound infections, we have developed protocols that measure biofilm dispersal both ex vivo and in vivo. We use a mouse surgical excision model that has been well-described to create biofilm-associated chronic wound infections. To monitor dispersal in vivo, we infect the wounds with bacterial strains that express luciferase. Once mature infections have established, we irrigate the wounds with a solution containing enzymes that degrade components of the biofilm EPS. We then monitor the location and intensity of the luminescent signal in the wound and filtering organs to provide information about the level of dispersal achieved. For ex vivo analysis of biofilm dispersal, infected wound tissue is submerged in biofilm-degrading enzyme solution, after which the bacterial load remaining in the tissue, versus the bacterial load in solution, is assessed. Both protocols have strengths and weaknesses and can be optimized to help accurately determine the efficacy of dispersal treatments.

Here, we describe ex vivo and in vivo methods for assessing bacterial dispersal from a wound infection in mice. This protocol can be utilized to test the efficacy of topical antimicrobial and anti-biofilm therapies, or to assess the dispersal capacity of different bacterial strains or species.

Biofilm-related infections are implicated in a wide array of chronic conditions such as non-healing diabetic foot ulcers, chronic sinusitis, reoccurring ...

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics

The development of antimicrobials is an expensive process with increasingly low success rates, which makes further investment in antimicrobial discovery research less attractive. Antimicrobial drug discovery and subsequent commercialization can be made more lucrative if a fail-fast-and-fail-cheap approach can be implemented within the lead optimization stages where researchers have greater control over drug design and formulation. In this article, the setup of an ex vivo ovine wounded skin model infected with Staphylococcus aureus&#160;is described, which is simple, cost-effective, high throughput, and reproducible. The bacterial physiology in the model mimics that during infection as bacterial proliferation is dependent on the pathogen&#39;s ability to damage the tissue. The establishment of wound infection is verified by an increase in viable bacterial counts compared to the inoculum. This model can be used as a platform to test the efficacy of emerging antimicrobials in the lead optimization stage. It can be contended that the availability of this model will provide researchers developing antimicrobials with a fail-fast-and-fail-cheap model, which will help increase success rates in subsequent animal trials. The model will also facilitate the reduction and refinement of animal use for research and ultimately enable faster and more cost-effective translation of novel antimicrobials for skin and soft tissue infections to the clinic.

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics

The protocol describes a step-by-step method to set up an ex vivo ovine wounded skin model infected with Staphylococcus aureus. This high-throughput model better simulates infections in vivo compared with conventional microbiology techniques and presents researchers with a physiologically relevant platform to test the efficacy of emerging antimicrobials.

The development of antimicrobials is an expensive process with increasingly low success rates, which makes further investment in antimicrobial discovery ...

Yucatan Minipig Burn Wound Model for Analysis of Multi-Depth Burns

A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds

Burn wound healing is a complex and long process. Despite extensive experience, plastic surgeons and specialized teams in burn centers still face significant challenges. Among these challenges, the extent of the burned soft tissue can evolve in the early phase, creating a delicate balance between conservative treatments and necrosing tissue removal. Thermal burns are the most common type, and burn depth varies depending on multiple parameters, such as temperature and exposure time. Burn depth also varies in time, and the secondary aggravation of the &#34;shadow zone&#34; remains a poorly understood phenomenon. In response to these challenges, several innovative treatments have been studied, and more are in the early development phase. Nanoparticles in modern wound dressings and artificial skin are examples of these modern therapies still under evaluation. Taken together, both burn diagnosis and burn treatments need substantial advancements, and research teams need a reliable and relevant model to test new tools and therapies. Among animal models, swine are the most relevant because of their strong similarities in skin structure with humans. More specifically, Yucatan minipigs show interesting features such as melanin pigmentation and slow growth, allowing for studying high phototypes and long-term healing. This article aims to describe a reliable and reproducible protocol to study multi-depth burn wounds in Yucatan minipigs, enabling long-term follow-up and providing a relevant model for diagnosis and therapeutic studies.

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

This protocol describes a reproducible multi-depth burn wound model in a Yucatan minipigs.

Swine Model of Biofilm Infection and Invisible Wounds

Podsumowanie

Przeglądaj więcej filmów

Pseudomonas aeruginosa and Saccharomyces cerevisiae Biofilm in Flow Cells

Microtiter Dish Biofilm Formation Assay

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Assessment of Acute Wound Healing using the Dorsal Subcutaneous Polyvinyl Alcohol Sponge Implantation and Excisional Tail Skin Wound Models.

Protocol to Create Chronic Wounds in Diabetic Mice

Severe Burn Injury in a Swine Model for Clinical Dressing Assessment

Assessing Biofilm Dispersal in Murine Wounds

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics

A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds